Xers Stock Analysis Xeris Biopharma Holdings Inc. Flat 6.04 Usd Performance And Sector Outlook 20260403 1 PFH Q1 2026 Earnings Prudential Financial Beats EPS Estimates as Revenue Data Remains Unavailable UVV Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions KALU Q1 2026 Earnings Massive EPS Surprise Highlights Operational Strength ENB Q1 2026 Earnings EPS Beats Estimates by 306 Amid Stable Operations CDXS Q1 2026 Earnings Surprise EPS Beat Despite Revenue Uncertainty BSAC Q1 2026 Earnings EPS Surpasses Estimates Shares Rise 358